Breast Cancer
Data from University of Nottingham provide new insights into breast cancer
Published in Women's Health Weekly, November 18th, 2010
Current study results from the report, 'Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women,' have been published. "Trials have shown superiority of aromatase inhibitors (AIs) over tamoxifen for post-menopausal oestrogen receptor-positive advanced breast cancer (ER+ABC). We previously reported the use of goserelin plus anastrozole (G+A) as second-line endocrine therapy for pre-menopausal ER+ABC," investigators in the United Kingdom report.
"We report clinical and endocrine data from G+A as first-line systemic therapy. Thirty-six patients (median age=44 years) with metastatic (N=28)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
CyberKnife Radiosurgery for Early-Stage Breast Cancer - Cervical Cancer
Data from A. Martinez et al provide new insights into cervical cancer - Breast Cancer
Data from University of Texas provide new insights into breast cancer - Ductal Carcinoma
Data on ductal carcinoma discussed by researchers at Soochow University, Department of Pathology - Breast Cancer
Evonail and Evodry Gaining Wide Acceptance at Breast Cancer Awareness Campaigns Amongst Patients Looking to Improve Quality of Life - Breast Cancer
Findings from A. De Luca and co-researchers advance knowledge in breast cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
